Title : Chemically modified heparins inhibit fibrinogen-bridged indirect adhesion between tumor cells and platelets.

Pub. Date : 2012 Feb

PMID : 22740939






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Chemically modified heparins inhibit fibrinogen-bridged indirect adhesion between tumor cells and platelets. Heparin fibrinogen beta chain Homo sapiens
2 In the present study, we aimed to detect the effects of 8 chemically modified heparins on the binding of fibrinogen to platelets or tumor cells using flow cytometry assays, as well as the fibrinogen-bridged adhesion of platelets and tumor cells using flow chamber assays. Heparin fibrinogen beta chain Homo sapiens
3 These data indicate that chemically modified heparins should be potential inhibitors for the fibrinogen-bridged indirect adhesion of platelets and tumor cells, which provides a novel explanation of the anti-adhesion property of heparin and proposes a new anti-metastatic target for cancer treatment. Heparin fibrinogen beta chain Homo sapiens
4 These data indicate that chemically modified heparins should be potential inhibitors for the fibrinogen-bridged indirect adhesion of platelets and tumor cells, which provides a novel explanation of the anti-adhesion property of heparin and proposes a new anti-metastatic target for cancer treatment. Heparin fibrinogen beta chain Homo sapiens